Unbound MEDLINE

Mycobacterium abscessus from respiratory isolates: activities of drug combinations. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] Journal article

 
TitleMycobacterium abscessus from respiratory isolates: activities of drug combinations.
Author(s)Cremades R, Santos A, Rodríguez JC, Garcia-Pachón E, Ruiz M, Royo G 
InstitutionSection of Microbiology and Section of Pneumology, Hospital General Universitario de Elche, Camí de L'Almàssera, no. 11, 03203, Elche, Spain.
SourceJ Infect Chemother 2009 Feb; 15(1):46-8.
MeSHAnti-Bacterial Agents
Drug Synergism
Humans
Microbial Sensitivity Tests
Mycobacteria, Atypical
Mycobacterium Infections, Atypical
Respiratory Tract Infections
AbstractMycobacterium abscessus is the most resistant of rapidly growing pathogenic mycobacteria. We performed a screening of the in vitro sterilizing capacity of various antibiotic combinations against two strains isolated from respiratory samples (in vitro activity of each antibiotic: 51 combinations of two drugs and 47 of three drugs). Our findings confirm that clarithromycin is the most useful drug. The combination of this drug with linezolid exhibits good activity. In addition, the fluoroquinolones and rifabutin in association with clarithromycin may have clinical utility because they are administered orally. Therapeutic alternatives in this type of infections should be evaluated in greater depth.
Languageeng
Pub Type(s)Journal Article
Research Support, Non-U.S. Gov't
PubMed ID19280301
  
Advertise on this site.